Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- National philanthropist, best-selling author, award-winning filmmaker, acclaimed speaker, and global media executive, Dr. Cheryl Polote Williamson, will...
-
Vancouver, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to report results from its 2025...
-
QUINCY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Plumas Bank, a wholly-owned subsidiary of Plumas Bancorp, has announced recent changes to its credit administration leadership team. Effective Jan....
-
PITTSBURGH, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Ellafi Federal Credit Union (“EFCU”),1 recently announced a cybersecurity incident, which impacted the personal information of seventeen thousand...
-
Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported a 1,200% year-over-year increase in administered therapies from 2024 to 2025, reflecting...
-
A Media Snippet accompanying this announcement is available by clicking on this link. SANDY, Utah, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mountain America Credit Union is strengthening its connection...
-
Kennewick, WA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) The IsoPet division reported an 800% year-over-year increase in administered therapies from 2024 to 2025, reflecting...
-
-- BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 enrolled patients remain on therapy -- -- Promising...
-
PITTSBURGH, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Loving and Living Center, PC dba Awakenings Center (“Awakenings”), a counseling services provider in North Carolina,1 recently announced a cybersecurity...
-
Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz® over treatment area of 240 cm2Completion of this study marks a key milestone...